| 臺北醫學大學 |
2009 |
Vancomycin-resistant enterococci in a tertiary teaching hospital in Taiwan
|
Yu-Chia Hsieh; Tsong-Yih Ou; Sing-On Teng; Wuan-Chan Lee; Yi-Chun Lin; Jann-Tay Wang; Shan-Chwen Chang; Wen-Sen Lee |
| 國立臺灣大學 |
2009 |
Vancomycin-Resistant Enterococci in a Tertiary Teaching Hospital in Taiwan
|
謝育嘉; 歐聰億; 鄧承恩; 李垣樟; 林怡君; 王振泰; 張上淳; 李文森; HSIEH, YU-CHIA; ON, TSONG-YIH; TENG, SING-ON; LEE, WUAN-CHAN; LIN, YI-CHUN; WANG, JANN-TAY; CHANG, SHAN-CHWEN; LEE, WEN-SEN |
| 臺大學術典藏 |
2022-05-13T08:05:02Z |
Vancomycin-resistant enterococci in a tertiary teaching hospital in Taiwan
|
Hsieh Y.-C.; Ou T.-Y.; Teng S.-O.; Lee W.-C.; Lin Y.-C.; JANN-TAY WANG; Chang S.-C.; Lee W.-S. |
| 臺北醫學大學 |
2009 |
Vancomycin-resistant enterococci in a tertiary teaching hospital in Taiwan.
|
Yu-Chia Hsieh; Tsong-Yih Ou; Sing-On Teng; Wuan-Chan Lee; Yi-Chun Lin; Jann-Tay Wang; Shan-Chwen Chang; Wen-Sen Lee |
| 國立臺灣大學 |
1999 |
Vancomycin-Resistant Enterococci in North-Eastern Taiwan
|
張上淳; 陳昶華; 盧進德; 戴惠敏; 徐快君; 羅勝雄; CHANG, SHAN-CHWEN; CHEN, CHANG-HUA; LU, DANIEL C-T; TAI, HUI-MING; HSU, KAU-CHUN; LO, SHENG-SHUNG |
| 臺大學術典藏 |
2020-12-30T02:45:21Z |
Vancomycin-resistant enterococci in north-eastern Taiwan
|
Tai H.M.; Lu D.C.; SHAN-CHWEN CHANG; Chen C.H.; Shan-Chwen Chang;Chen C.H.;Lu D.C.;Tai H.M.;Hsu K.C.;Lo S.S.; Hsu K.C.; Lo S.S. |
| 中國醫藥大學 |
2010-09 |
Vancomycin-resistant enterococci peritonitis development after shifting from hemodialysis to peritoneal dialysis
|
張智銘(Chih-Ming Chang); 梁志嘉(Chih-Chia Liang); 葉宏傑(Hung-Chieh Yeh); 楊雅斐(Ya-Fei Yang); 王怡寬(I-Kuan Wang); 林信宏(Hsin-Hung Lin)*; 黃秋錦(Chiu-Ching Huang) |
| 國家衛生研究院 |
2004-06-01 |
Vancomycin-resistant Enterococcus (VRE) carriage and infection in intensive care units
|
Yeh, KM; Siu, LK; Chang, JC; Chang, FY |
| 國立臺灣大學 |
1993-07 |
Vancomycin.
|
Wu, Fe-lin Lin |
| 國立臺灣大學 |
2008 |
vancomycin在使用持續性低效率血液透析過濾(SLEDD-f) 的病人之藥品動態學與劑量學研究
|
林欣儀; Lin, Shin-Yi |
| 中國醫藥大學 |
2006-12-23 |
Vancomycin引起之嗜中性白血球減少症
|
楊蕙菁; 鍾尚容; 潘美如; 林明薰; 鄞玉娟; 郭啟文* |
| 國家衛生研究院 |
2023 |
Vancomycin治療伊莉莎白菌之體外、動物、臨床效果，與殺菌作用機轉之探究
|
郭書辰 |
| 國立成功大學 |
2024-07-16 |
Vancomycin波谷濃度與急性腎損傷之間的風險因子研究
|
曾湘涵; Tseng, Siang-Han |
| 臺大學術典藏 |
2018-09-10T05:57:47Z |
Vandermonde-form preserving matrices and the generalized signal richness preservation problem
|
Su, B.; Vaidyanathan, P.P.; BORCHING SU |
| 臺大學術典藏 |
2022-08-19T00:20:57Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Cheng A.-L.; Meng R.; Chao Y.; Hsieh T.-Y.; Huang W.-T.; Hwang W.-S.; Yu C.-W.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; CHIUN HSU |
| 國立臺灣大學 |
2012 |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, Chiun; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii; 鄭安理; 許駿; 游治維 |
| 臺大學術典藏 |
2018-09-10T09:15:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, C. and Yang, T.-S. and Huo, T.-I. and Hsieh, R.-K. and Yu, C.-W. and Hwang, W.-S. and Hsieh, T.-Y. and Huang, W.-T. and Chao, Y. and Meng, R. and Cheng, A.-L.; Hsu, Chiun;Yang, Tsai-Sheng;Huo, Teh-Ia;Hsieh, Ruey-Kuen;Yu, Chih-Wei;Hwang, Wei-Shou;Hsieh, Tsai-Yuan;Huang, Wen-Tsung;Chao, Yee;Meng, Robin;Cheng, Ann-Lii; 鄭安理 ;許駿 ;游治維; CHIH-WEI YU; Hsu, Chiun; ANN-LII CHENG; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii |
| 臺大學術典藏 |
2020-04-10T12:51:14Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Chiun Hsu;Yang T.-S.;Huo T.-I.;Hsieh R.-K.;Yu C.-W.;Hwang W.-S.;Hsieh T.-Y.;Huang W.-T.;Chao Y.;Meng R.;Cheng A.-L.; Chiun Hsu; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L. |
| 臺大學術典藏 |
2020-07-09T02:57:03Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
CHIH-WEI YU; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; Hsu C. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu C.; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG |
| 臺大學術典藏 |
2020-05-26T09:27:14Z |
Vandetanib plus pemetrexed for the second-line treatment of advanced non - small-cell lung cancer: A randomized, double-blind phase III trial
|
De Boer R.H;Arrieta ?;Chih-Hsin Yang;Gottfried M;Chan V;Raats J;De Marinis F;Abratt R.P;Wolf J;Blackhall F.H;Langmuir P;Milenkova T;Read J;Vansteenkiste J.F.; De Boer R.H; Arrieta ?; CHIH-HSIN YANG; Gottfried M; Chan V; Raats J; De Marinis F; Abratt R.P; Wolf J; Blackhall F.H; Langmuir P; Milenkova T; Read J; Vansteenkiste J.F. |
| 國立臺灣大學 |
2011 |
Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non- Small-Cell Lung Cancer: A Randomized, Double-Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Versus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc): A Randomized, Double-Blind Phase Iii Trial (Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Vs Pemetrexed as 2nd-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc); a Randomized, Double- Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pernetrexed Versus Pemetrexed as 2nd-Line Therapy in Patients with Advanced Nsclc: A Randomized, Double-Blind Phase Iii Trial ( Zeal)
|
楊志新; YANG, CHIH-HSIN |
